Imino [4+4] cycloaddition products as exclusive and biologically relevant acrolein-amine conjugates are intermediates of 3-formyl-3,4-dehydropiperidine(FDP), an acrolein biomarker

被引:13
|
作者
Takamatsu, Masayuki [1 ]
Fukase, Koichi [2 ]
Kurbangalieva, Almira [3 ]
Tanaka, Katsunori [1 ,3 ]
机构
[1] RIKEN, Biofunct Synthet Chem Lab, Wako, Saitama 3510198, Japan
[2] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 5600043, Japan
[3] Kazan Fed Univ, A Butlerov Inst Chem, Biofunct Chem Lab, Kazan 420008, Russia
基金
日本学术振兴会;
关键词
Acrolein; Biologically relevant amine; Biomarker 1,5-Diazacyclooctane; 3-Formyl-3,4-dehydropiperidine(FDP); Imino [4+4] cycloaddition; 2,6,9-Triazabicyclo[3.3.1] nonane; PROTEIN-BOUND ACROLEIN; SOLUBLE GUANYLATE-CYCLASE; OXIDATIVE STRESS; CELLS; 6-PI-AZAELECTROCYCLIZATION; OXIDASE; MARKERS; LYSINE; ADDUCT; MICE;
D O I
10.1016/j.bmc.2014.09.045
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We demonstrated synthetically that the eight-membered heterocycles 2,6,9-triazabicyclo[3.3.1] nonanes and 1,5-diazacyclooctanes are the initial and exclusive products of the reaction, through an imino [4+4] cycloaddition, of biologically relevant amines with acrolein. The stabilities of the aminoacetals within the eight-membered heterocycles determined whether the product was subsequently transformed gradually into the 3-formyl-3,4-dehydropiperidine (FDP), which is widely used as an oxidative stress marker. The reactivity profiles discovered in this study suggested that some of the imino [4+4] cycloaddition products are reactive intermediates of FDP and contribute to the mechanisms underlying the oxidative stress response to acrolein. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6380 / 6386
页数:7
相关论文
共 1 条
  • [1] Exclusive formation of imino[4+4]cycloaddition products with biologically relevant amines: plausible candidates for acrolein biomarkers and biofunctional modulators
    Tsutsui, Ayumi
    Pradipta, Ambara R.
    Saigitbatalova, Elena
    Kurbangalieva, Almira
    Tanaka, Katsunori
    MEDCHEMCOMM, 2015, 6 (03) : 431 - 436